This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003 May;3(5):534-42.

doi: 10.1034/j.1600-6143.2003.00079.x.

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies

Leslie M Shaw¹, Magdalena Korecka, Raman Venkataramanan, Lee Goldberg, Roy Bloom, Kenneth L Brayman

Affiliations

PMID: 12752309
DOI: 10.1034/j.1600-6143.2003.00079.x

Free article

Review

Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies

Leslie M Shaw et al. Am J Transplant. 2003 May.

Free article

. 2003 May;3(5):534-42.

doi: 10.1034/j.1600-6143.2003.00079.x.

Authors

Leslie M Shaw¹, Magdalena Korecka, Raman Venkataramanan, Lee Goldberg, Roy Bloom, Kenneth L Brayman

Affiliation

¹ Department of Pathology & Laboratory Medicine, School of Pharmacy, University of Pittsburgh, PA 15261, USA. shawlmj@mail.med.upenn.edu

PMID: 12752309
DOI: 10.1034/j.1600-6143.2003.00079.x

No abstract available

PubMed Disclaimer

Similar articles

Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients.
Shaw LM, Korecka M, DeNofrio D, Brayman KL. Shaw LM, et al. Clin Biochem. 2001 Feb;34(1):17-22. doi: 10.1016/s0009-9120(00)00184-3. Clin Biochem. 2001. PMID: 11239510 Review.
The pharmacokinetics and pharmacodynamics of mycophenolate mofetil in younger and elderly renal transplant recipients.
Tang JT, de Winter BC, Hesselink DA, Sombogaard F, Wang LL, van Gelder T. Tang JT, et al. Br J Clin Pharmacol. 2017 Apr;83(4):812-822. doi: 10.1111/bcp.13154. Epub 2016 Nov 30. Br J Clin Pharmacol. 2017. PMID: 27753146 Free PMC article.
Population pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant period.
Dong M, Fukuda T, Cox S, de Vries MT, Hooper DK, Goebel J, Vinks AA. Dong M, et al. Br J Clin Pharmacol. 2014 Nov;78(5):1102-12. doi: 10.1111/bcp.12426. Br J Clin Pharmacol. 2014. PMID: 24837828 Free PMC article.
Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
Klupp J, van Gelder T, Dambrin C, Regieli J, Boeke K, Billingham ME, Morris RE. Klupp J, et al. Transplant Proc. 2001 May;33(3):2170-1. doi: 10.1016/s0041-1345(01)02064-4. Transplant Proc. 2001. PMID: 11377490 No abstract available.
Monitoring of mycophenolic acid in clinical transplantation.
Shaw LM, Pawinski T, Korecka M, Nawrocki A. Shaw LM, et al. Ther Drug Monit. 2002 Feb;24(1):68-73. doi: 10.1097/00007691-200202000-00012. Ther Drug Monit. 2002. PMID: 11805725 Review. No abstract available.

See all similar articles

Cited by

The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.
Filler G, Alvarez-Elías AC, McIntyre C, Medeiros M. Filler G, et al. Pediatr Nephrol. 2017 Jan;32(1):21-29. doi: 10.1007/s00467-016-3352-2. Epub 2016 Feb 26. Pediatr Nephrol. 2017. PMID: 26921212 Review.
Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients.
Sunder-Plassmann G, Reinke P, Rath T, Wiecek A, Nowicki M, Moore R, Lutz J, Gaggl M, Ferkl M. Sunder-Plassmann G, et al. Transpl Int. 2012 Jun;25(6):680-6. doi: 10.1111/j.1432-2277.2012.01475.x. Epub 2012 Apr 16. Transpl Int. 2012. PMID: 22500920 Free PMC article. Clinical Trial.
Mycophenolic acid area under the curve recovery time following rifampicin withdrawal.
Annapandian VM, Fleming DH, Mathew BS, John GT. Annapandian VM, et al. Indian J Nephrol. 2010 Jan;20(1):51-3. doi: 10.4103/0971-4065.62091. Indian J Nephrol. 2010. PMID: 20535273 Free PMC article.
Influence of UGT1A8 and UGT2B7 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
Kagaya H, Inoue K, Miura M, Satoh S, Saito M, Tada H, Habuchi T, Suzuki T. Kagaya H, et al. Eur J Clin Pharmacol. 2007 Mar;63(3):279-88. doi: 10.1007/s00228-006-0248-2. Epub 2007 Jan 9. Eur J Clin Pharmacol. 2007. PMID: 17211619
Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients.
Jung HY, Lee S, Jeon Y, Choi JY, Cho JH, Park SH, Kim YL, Kim HK, Huh S, Won DI, Kim CD. Jung HY, et al. J Korean Med Sci. 2020 Jun 22;35(24):e185. doi: 10.3346/jkms.2020.35.e185. J Korean Med Sci. 2020. PMID: 32567256 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov